Skip to main content
Premium Trial:

Request an Annual Quote

Allen Lamb, Vineet Bansal, Debbie Corazzelli

Premium
Allen Lamb has been appointed laboratory director at Signature Genomic Laboratories.
 
Prior to joining Signature, Lamb was a medical director in the cytogenetics laboratory at University of Utah ARUP Laboratories and an associate professor of clinical pathology in the department of pathology at the University of Utah School of Medicine. He previously worked at Genzyme Genetics.
 
Lamb is a founding fellow of the American College of Medical Genetics and is certified by the American Board of Medical Genetics in clinical cytogenetics and clinical molecular genetics. He holds a PhD in molecular biology and biochemistry from Wesleyan University and completed his postdoc at the University of North Carolina and Harvard Medical School.
 

 
Med BioGene has appointed Vineet Bansal to be director of product launch and marketing, and has appointed Debbie Corazzelli as senior advisor of diagnostics commercialization.
 
Both had previously worked at Brisbane, Calif.-based XDx and were involved with that company’s gene expression-based test for managing heart transplant patients to market.
 
Bansal holds an MBA from the University of California, Berkeley, and an MSc from Rutgers University. Corazelli holds an MBA from the University of California, Los Angeles.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.